# Phase 2 depression trials recruiting: 74 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 74 trials in phase 2 for depression that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2 depression trials: 74 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2/depression

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 74
- Recruiting or not yet: 74
- Read on: November 19, 2026

## Trials

The 25 newest of 74, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 17, 2026 | NCT07942064 | Remote Exercise iNtErvention for Wellbeing (RENEW) Trial | University of British Columbia | Phase 2 | Not yet recruiting | Exercise Adherence (Primary), Depressive Symptoms (Secondary), Anxiety (Secondary), Presenteeism Secondary), Wellbeing... | 664 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07942064) |
| November 12, 2026 | NCT07934043 | Exploring Ketamine's Effects on Depression and Anxiety in Adults With Low Vision | Stanford University | Phase 2 | Not yet recruiting | Depression, Anxiety, Low Vision | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07934043) |
| November 2, 2026 | NCT07909408 | Psilocybin FCR Early-Stage Breast Cancer | NYU Langone Health | Phase 2 | Not yet recruiting | Early-stage Breast Cancer, Fear of Cancer Recurrence, Anxiety, Depression | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07909408) |
| October 26, 2026 | NCT07895134 | Psilocybin for Depression in Veterans | VA Office of Research and Development | Phase 2 | Not yet recruiting | Major Depression | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07895134) |
| October 9, 2026 | NCT07868718 | Peer Support for Family Caregivers of Older Adults Living With Dementia | Ohio State University | Phase 2 | Not yet recruiting | Caregiver Burden, Caregiver Burnout, Caregiver Anxiety, Alzheimer Disease Dementia | 344 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07868718) |
| October 1, 2026 | NCT07852728 | HBOT Effects on First Responders' Cognition and Well-Being | Sponsor not shown (see the record) | Phase 2 | Recruiting | Traumatic Brain Injury, PTSD - Post Traumatic Stress Disorder, Anxiety, Depression, Post Concussion Symptoms | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07852728) |
| September 29, 2026 | NCT07845604 | Precision Depression Adalimumab Trial | Sponsor not shown (see the record) | Phase 2 | Recruiting | Major Depressive Disorder (MDD) | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07845604) |
| August 19, 2026 | NCT07772531 | A Study to Evaluate BMS-986511 in Adults With Major Depressive Disorder | Bristol-Myers Squibb | Phase 2 | Recruiting | Major Depressive Disorder | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07772531) |
| August 17, 2026 | NCT07768618 | Electrophysiologic Mechanisms of Ketamine Antidepressant Response | Emory University | Phase 2 | Not yet recruiting | Epilepsy, Depressive Symptoms | 37 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07768618) |
| June 29, 2026 | NCT07673380 | Leveraging mHealth to Promote Opioid Use Recovery and Mental Health Among Residents of a Medium-Sized Midwestern City | Washington University School of Medicine | Phase 2 | Recruiting | Opioid Use, Stimulant Use, Depression and Anxiety Symptoms | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07673380) |
| June 25, 2026 | NCT07667738 | Evaluating the Effectiveness of the Common Elements Treatment Approach (CETA) in Peru: Mechanisms of Individual and Intergenerational Change | University of Notre Dame | Phase 2 | Recruiting | Violence, Parenting, Poverty, Depression, Mental Health, Posttraumatic Stress, Economic Factors, Child Psychology | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07667738) |
| June 16, 2026 | NCT07649291 | Duloxetine and aeRobic Exercise to Improve Function in VEterans With Knee Osteoarthritis (DRIVE) | VA Office of Research and Development | Phase 2 | Not yet recruiting | Knee Osteoarthritis, Pain, Depression | 102 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07649291) |
| June 10, 2026 | NCT07639359 | Subanesthetic Ketamine Infusions for Depressive Symptoms in Intensive Care Unit Patients | Hospital Italiano de Buenos Aires | Phase 2 | Recruiting | Critical Illness, Depressive Symptoms | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07639359) |
| June 2, 2026 | NCT07621237 | A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD) | Tonix Pharmaceuticals, Inc. | Phase 2 | Recruiting | Major Depressive Episode (MDE), Major Depressive Disorder (MDD), Depression | 360 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07621237) |
| May 28, 2026 | NCT07610473 | A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression | Draig Therapeutics Ltd | Phase 2 | Recruiting | Major Depressive Disorder (MDD) | 118 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07610473) |
| May 28, 2026 | NCT07610369 | The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease | Yale University | Phase 2 | Recruiting | Depression, Parkinson's Disease (PD) | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07610369) |
| May 27, 2026 | NCT07608796 | JAK Signaling in Depression and Cognition in Male Football Players | Emory University | Phase 2 | Recruiting | Depressive Symptoms, Cognitive Symptom | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07608796) |
| May 12, 2026 | NCT07582120 | Psilocybin-Assisted Therapy as a Treatment for Depression | Washington University School of Medicine | Phase 2 | Recruiting | Depression | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07582120) |
| May 4, 2026 | NCT07565909 | Group Retreat Psilocybin Therapy for Healthcare Clinicians With Loss of Meaning in Their Work and Symptoms of Depression | University of Washington | Phase 2 | Not yet recruiting | Depression, Anxiety | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07565909) |
| April 23, 2026 | NCT07547709 | Computerized Cognitive Behavioral Therapy-Depression (cCBT-D) for Caregivers of Veterans | VA Eastern Colorado Health Care System | Phase 2 | Not yet recruiting | Depression | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07547709) |
| April 6, 2026 | NCT07512284 | Mindfulness Engaged Neurostimulation for Depression (MEND II) | University of California, San Diego | Phase 2 | Recruiting | Depression, Treatment Resistant Depression, Major Depressive Disorder, Depressive Disorder, Depressive Symptoms | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07512284) |
| March 25, 2026 | NCT07493317 | Neutralizing Interleukin (IL)-6 | Icahn School of Medicine at Mount Sinai | Phase 2 | Recruiting | Major Depressive Disorder | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07493317) |
| February 19, 2026 | NCT07420205 | Sleep Health in U.S. Marines | San Diego State University | Phase 2 | Recruiting | Depression, Suicidality, Sleep | 860 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07420205) |
| February 12, 2026 | NCT07405606 | Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder | Centre for Addiction and Mental Health | Phase 2 | Recruiting | Major Depressive Disorder (MDD), Alcohol Use Disorder (AUD) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07405606) |
| December 24, 2025 | NCT07300969 | A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression | Draig Therapeutics Ltd | Phase 2 | Recruiting | Major Depressive Disorder (MDD) | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07300969) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| VA Office of Research and Development | 6 |
| Emory University | 3 |
| Washington University School of Medicine | 3 |
| M.D. Anderson Cancer Center | 2 |
| Stanford University | 2 |
| University of Colorado, Boulder | 2 |
| NYU Langone Health | 2 |
| Draig Therapeutics Ltd | 2 |
| National Institute of Mental Health (NIMH) | 2 |
| Massachusetts General Hospital | 2 |
| Ohio State University | 2 |
| University of California, Los Angeles | 2 |
| VA Eastern Colorado Health Care System | 2 |
| University of British Columbia | 2 |
| Seaport Therapeutics | 1 |
| Centre Hospitalier Universitaire Vaudois | 1 |
| University Hospital, Tours | 1 |
| [Tonix Pharmaceuticals, Inc.](https://specstream.ai/data/clinical-trials/company/tonix-pharmaceuticals-inc) | 1 |
| Kansas State University | 1 |
| Afasci Inc | 1 |
| University of California, San Diego | 1 |
| University of Washington | 1 |
| Hospital Italiano de Buenos Aires | 1 |
| Henry Ford Health System | 1 |
| San Diego State University | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 57 |
| Canada | 7 |
| Czechia | 4 |
| Bulgaria | 2 |
| Germany | 2 |
| Poland | 2 |
| Switzerland | 2 |
| Hungary | 1 |
| Slovakia | 1 |
| Argentina | 1 |
| Peru | 1 |
| United Kingdom | 1 |
| Sweden | 1 |
| Denmark | 1 |
| Netherlands | 1 |
| Portugal | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Contract law firms in the United States](https://specstream.ai/data/businesses/contract-law-firms/united-states)
- [Naturopathic clinics in the United States](https://specstream.ai/data/businesses/naturopathic-clinics/united-states)
- [American restaurants in the United States](https://specstream.ai/data/businesses/american-restaurants/united-states)
- [Genetics practices in the United States](https://specstream.ai/data/businesses/genetics-practices/united-states)
- [Scandinavian restaurants in the United States](https://specstream.ai/data/businesses/scandinavian-restaurants/united-states)
- [Chimney sweeps in the United States](https://specstream.ai/data/businesses/chimney-sweeps/united-states)
